24th Annual Meeting of the American Venous Forum Scheduled for February 8-11, 2012, in Orlando by Eileen Masciale


The American Venous Forum (AV F) is holding its 24th Annual Meeting from February 8–11, 2012, in Orlando. This is the premier meeting for healthcare providers, researchers, and trainees with an interest in venous disease, as it brings together internationally recognized experts on all aspects of venous disease, diagnosis, pathophysiology, and treatment. In addition to its focus on patient care, the AV F Annual Meeting also has a significant research focus, with scientists from all over the world presenting their most recent work to improve understanding of vein disease.

According to Dr. Seshadri Raju, President of the American Venous Forum, “The annual meeting will feature an unprecedented line-up of scientific sessions and workshops, with the absolute leaders in the field presenting and interacting with attendees as they all work together to advance the field of venous disease.” More than 500 vascular and general surgeons, interventional radiologists, interventional cardiologists, phlebologists, plastic surgeons, physician assistants, nurse practitioners, and other medical professionals who treat venous disease are expected to attend. The Annual Meeting is open to members of the AV F and other professionals who are not members at the time of registration.

In 2011, there were 26 countries represented at the AV F Annual Meeting: Argentina, Belgium, Brazil, Canada, Cyprus, Denmark, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Mexico, Netherlands, New Zealand, Romania, Russia, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, the UK, and the USA. An expansive international turnout is expected again at the 2012 meeting.

The level of excellence at the Annual Meeting is maintained by a rigorous peer review of the abstracts that are submitted. The rigor of the presentations and the open exchange of ideas among attendees and presenters combine to make the AV F’s Annual Meeting a positive, high quality experience for all who attend.

The AV F is an international consortium of venous and lymphatic specialists dedicated to improving patient care. Its mission is to promote venous and lymphatic health through innovative research, education, and technology.

New This Year

For the first time, the AV F Annual Meeting will feature subsection meetings in various specialties, such as varicose veins/sclerotherapy, bio-engineering/devices, and AV malformations/ lymphology. The subsection meetings were created to provide a more focused format that would foster more meaningful dialogue among physicians and researchers on specific types of venous disease and treatments.

Of special significance, the AV malformations/ lymphology subsection meeting has been named The Villavicencio Forum on AV Malformations/Lymphology to honor Dr. J. Leonell Villavicencio, the esteemed vascular surgeon who was Professor of Surgery at the Uniformed Services University of the Health Sciences, for his pioneering contributions to the field. He will deliver the inaugural lecture with additional lectures in lymphology by other experts in this area.

Another subsection meeting will be Venous Care for Nurses/ Nurse Practitioners, led by Dr. Fedor Lurie, Clinical Professor of Vascular Surgery at the University of Hawaii. In this section, Dr. Nicos Labropoulos, Professor of Surgery at Stony Brook (NY ) University Medical Center, will demonstrate the technique he pioneered on the examination of iliac veins to vascular technologists

Bioengineering/devices will have a subsection program led by scientist Roger
Kamm, Research Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology, an authority on fluid flow. The wound care/compression section will feature talks by Dr. Hugo Partsch, Professor of Dermatology at the University of Vienna, Austria and Dr. William Ennis, of Chicago, both renowned for their work in compression and wound care, respectively. There will also be a special subsection on superficial venous disease/sclerotherapy chaired by Lowell S. Kabnick, MD , Director of the New York University Vein Center.

“The subsection format is one example of how we are always looking to improve our meeting outcomes. These meetings will promote in-depth attention to topics in the various fields that goes beyond what is possible in the general session,” said Dr. Raju.

This year, the David Sumner Venous Summit will feature: True Controversies in Venous Disease. Chaired by Robert McLafferty, MD , Professor, Division of Vascular Surgery, Southern Illinois University School of Medicine, and President-Elect of the American Venous Forum, issues to be addressed in a point/ counterpoint debate format are:

• The role of inferior vena cava filters in trauma patients
• The role of endovascular treatment of CCSVI and multiple sclerosis
• The role of foam sclerotherapy for the majority of varicose vein treatment
• The role of the ACCP guidelines in perioperative venous thromboembolism prophylaxis
• The role of primary valve dysfunction in the development of varicose veins

Annual Meeting Highlights The five-day AV F Annual Meeting offers a variety of programming opportunities. There are multiple symposia, presentations, and workshops on a range of clinical issues related to venous disease. Original research reports, Ask the Expert sessions and poster sessions are conference mainstays based on the popularity among attendees.

One of the highlights each year is the Dr. Eugene Strandness Lecture, named for a founding pioneer of the AV F. The 2012 lecture will presented by Dr. Paolo Prandoni, University of Padua (Italy). Dr. Prandoni, a world renowned authority on venous thromboembolism, will give a talk titled, Venous and Arterial Thrombosis to illuminate the relationship between arterial and venous thrombosis.

Also featured at the meeting are scientific sessions that provide an in-depth look at deep vein thrombosis, chronic venous insufficiency, superficial vein disease, IVC and filters, lymphedema and compression, and other critical aspects of venous disease.

American Medical Association (AMA ) Physician’s Recognition Award (PRA ) Category 1 Credits™ will be provided for select program elements.

In addition, there will be industry updates and exhibits from a select group of companies that offer the latest products for diagnosis and treatment of venous disease.

Grants to be Presented at Annual Meeting

In addition to the various symposia, presentations, and workshops that will be offered, the AV F will be presenting its 2012 BSN-JOBST Research Fellowship at the Annual Meeting. For the second consecutive year, this grant will be a $50,000 award, double the amount given out in the past.

The AVF will also present two Servier Traveling Fellowship Awards at the meeting. Supported by an Educational Grant by Servier International (Les Laboratories Servier), a French drug company, the award enables two researchers to present their work at the European Venous Forum Meeting in June 2012, and report back to the AVF on their experience the following year.

AVF Updates at the Annual Meeting

The AV F offers a variety of education opportunities for healthcare providers throughout the year and will be providing updates at the Annual Meeting. These include:

AVF-Sponsored Registry, launched at the 2011 Annual Meeting, was created to assist doctors in their clinical practice while creating a resource for tracking treatment and outcomes of venous disease. The Registry will be comprised of five modules; two have been launched and three are under development. Each module focuses on one particular aspect of venous disease and offers several clinical practice tools as well as the ability to run specific benchmarking queries in real time. The modules are:
• Varicose vein module, which was launched in February 2011
• IVC filter module, which was launched in June 2011
• Stent module, which is scheduled to launch in the Fall of 2011
• DVT thrombectomy/lysis module
• Upper Extremity DVT module

Meeting attendees will have an opportunity for on-site demonstrationsand can register to participate in the registry.

AVF National Venous Screening Program, which was established six years ago to increase public awareness of acute and chronic venous diseases through education, identification, and empowerment, and remains as the nation’s only dedicated organized nonprofit venous screening effort. There are screening sites throughout the US; providers can find out how they can become a screening site on line or at the Annual Meeting.

Host Hotel: Loews Royal Pacific Resort at Universal Orlando®

The AV F Annual Meeting will be held at the Loews Royal Pacific Resort at Universal Orlando®. This luxurious resort offers an exotic South Seas flavor with an abundance of activities and entertainment on-site. In addition, guests can take advantage of exclusive privileges just steps away at the Universal Orlando ® theme park.


Magazine Archives


Volume 1 / 2008

Volume 2 / 2009

Volume 3 / 2010

Volume 4 / 2011

Volume 5 / 2012

Volume 6 / 2013

Volume 7 / 2014



Download the
2014 Media kit